Explanation: Antibody-dependent enhancement (ADE) occurs when antibodies are unable to neutralize a virus’ infectivity, but instead enhance a virus’ ability to infect cells. Although ADE has been observed in humans who received the dengue vaccine, as well as in individuals that received a vaccine candidate for the respiratory syncytial virus, the evidence from COVID-19 vaccine clinical trials so far have not shown more severe disease occurring in vaccinated participants. People who have been given the COVID-19 vaccine will continue to be closely monitored to determine whether ADE occurs.Read the Full Article (Science Feedback)
This false claim originated from: Facebook users, Facebook
The #CoronavirusFacts database records fact-checks published since the beginning of the COVID-19 outbreak. The pandemic and its consequences are constantly evolving and data that was accurate weeks or even days ago might have changed. Remember to check the date when the fact-check you are reading was published before sharing it.